Related Experiment Video
Updated: Jul 15, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Free energy along drug-protein binding pathways interactively sampled in virtual reality
Helen M Deeks1, Kirill Zinovjev2,3, Jonathan Barnoud1,4
1Center for Computational Chemistry, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.
This study introduces interactive molecular dynamics in virtual reality (iMD-VR) combined with free energy (FE) calculations. This novel iMD-VR-FE approach efficiently explores molecular dynamics and protein-ligand unbinding pathways.
Area of Science:
- Computational Biology
- Biophysics
- Molecular Dynamics
Background:
- Understanding protein-ligand interactions is crucial for drug discovery.
- Exploring molecular dynamics and binding pathways requires advanced computational methods.
Purpose of the Study:
- To present a novel two-step approach, iMD-VR-FE, combining interactive molecular dynamics in virtual reality (iMD-VR) with free energy (FE) calculations.
- To explore biological processes at the molecular level, focusing on protein-ligand unbinding pathways.
Main Methods:
- Stage one: Utilizes a human-in-the-loop iMD-VR framework to generate diverse protein-ligand unbinding pathways.
- Stage two: Employs iMD-VR-sampled pathways to define reaction coordinates for free energy (FE) calculations.
- Applies the iMD-VR-FE method to study benzamidine ligand unbinding from trypsin.
Main Results:
- The iMD-VR-FE approach yields consistent binding free energy values across different pathways.
- Free energy profiles effectively distinguish energetic differences between various protein-ligand conformations.
- Identifies metastable states along the unbinding pathways, providing detailed mechanistic insights.
Conclusions:
- The iMD-VR-FE method offers an intuitive and efficient way to test hypotheses for biomolecular pathways.
- Researchers can gain both qualitative and quantitative insights into molecular dynamics and binding processes.
- This approach enhances the exploration of complex biological systems at the molecular level.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Distribution: Plasma Protein Binding
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...